The simultaneous targeted Inhibition of ISG15 and HMGCR disrupts cancer stemness through metabolic collapse and induces synthetic lethality in pancreatic ductal adenocarcinoma. The gene discussed is HMGCR; the disease is pancreatic ductal adenocarcinoma.